Sono Tek CORP

Market Movers (8-K)

See all →
NASDAQ
Sono-Tek Corporation announced fiscal second quarter and first half FY27 results, highlighting a 289% surge in medical market sales and expanded gross margins, while reiterating full-year revenue guidance.
NASDAQ
Sono-Tek Corporation held its annual shareholder meeting on August 20, 2026, where directors were elected and independent auditors were ratified.
NASDAQ
Sono-Tek Corporation announced a robust first quarter for fiscal year 2027, with a 10% increase in net sales and significant improvements in profitability driven by strong medical sector demand.
Better than expected
NASDAQ
Sono-Tek Corporation achieved its second consecutive year of over $20 million in revenue and an 81% increase in operating income for fiscal year 2026.
NASDAQ
Sono-Tek Corporation reported its seventh consecutive quarter of over $5 million in revenue, with gross margin expanding to 50% and record backlog of $12.3 million, despite a slight dip in net sales.
NASDAQ
Sono-Tek Corporation has entered into new executive agreements with its top officers, enhancing change of control protections.

Quarterly Earnings (10-Q)

See all →
NASDAQ
Sono-Tek Corporation announced a 10% increase in net sales for the first quarter of fiscal year 2027, driven by strong performance in the medical market.
Better than expected
NASDAQ
Sono-Tek Corporation announced a 24% increase in net income for the third quarter of fiscal 2026, driven by improved gross profit margins and operating leverage, despite a slight dip in overall sales.
Better than expected
Delay expected
NASDAQ
Sono-Tek Corporation announced significant increases in net income and operating profit for the second quarter and first half of fiscal 2026, driven by improved gross margins and reduced operating expenses, despite modest sales growth.
Delay expected
Better than expected
NASDAQ
Sono-Tek Corporation announced a significant increase in first-quarter net income and operating profit, fueled by robust sales in the alternative energy sector, even as cash flow from operations declined and a key customer requested a payment delay.
Delay expected
Better than expected
NASDAQ
Sono-Tek Corporation's Q3 2025 results show a decrease in net sales and gross profit, but a significant increase in sales to the alternative energy market.
Worse than expected
NASDAQ
Sono-Tek Corporation's Q2 2025 results show a decrease in net sales and operating income, but a record high backlog and growth in the clean energy and electronics sectors.
Worse than expected

Annual Reports (10-K)

NASDAQ
Sono-Tek Corporation achieved record annual net sales of $20.9 million for fiscal 2026, driven by strong demand in medical and electronics markets.
Capital raise
NASDAQ
Sono-Tek Corporation achieved record net sales of $20.5 million in fiscal year 2025, a 4% increase, primarily fueled by strong demand in the Alternative/Clean Energy market, though gross profit and net income saw a slight decrease.
Capital raise
NASDAQ
Sono-Tek Corporation's fiscal year 2024 saw a significant 31% increase in net sales, reaching $19.7 million, primarily fueled by growth in the alternative/clean energy, industrial, and medical markets.
Better than expected

Insider Trading (Form 4)

See all →
NASDAQ
Maria T Kuha, VP of Sono Tek Corp, reported multiple transactions in common stock on October 14, 2026.
NASDAQ
Joseph Riemer, a Director of Sono Tek Corp, reported multiple transactions in common stock on October 12, 2026.
NASDAQ
Stephen James Bagley, CFO of Sono Tek Corp, reported multiple transactions in common stock on October 12, 2026.
NASDAQ
Christopher Cichetti, COO of Sono Tek Corp, reported multiple transactions in common stock on October 8, 2026.
NASDAQ
Brian Lewis Booth, Vice President of Sono Tek Corp, reported multiple transactions in common stock on October 6, 2026.
NASDAQ
Christopher L Coccio, a Director of Sono Tek Corp, reported multiple transactions in common stock on October 5, 2026.

Proxy Statements (Def-14A)

NASDAQ
Sono-Tek Corporation announces its 2026 Annual Meeting of Shareholders, scheduled for August 20, 2026, to elect directors and ratify auditor appointments.
NASDAQ
Sono-Tek Corporation's latest proxy statement outlines the agenda for its August 21, 2025 Annual Meeting, focusing on director elections, auditor ratification, and advisory votes on executive compensation and its frequency.
Worse than expected
NASDAQ
Sono-Tek Corporation's proxy statement details the upcoming annual meeting, director nominations, executive compensation, and auditor ratification.

Schedule 13G - Passive Investments

NASDAQ
Emancipation Management LLC, Circle N Advisors, LLC, and Charles Frumberg have jointly reported beneficial ownership of 34.7% of Sono Tek Corp's common stock as of December 31, 2024.